Jean-Philippe Collet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean-Philippe Collet has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Anne Bellemain-Appaix
Centre hospitalier La Fontonne, 107 avenue de Nice, 06600 Antibes, France
24 shared publications- Olivier Barthelemy
CHU Pitié-Salpétrière, Cardiologie, Paris, France
19 shared publications - Gilles Montalescot
Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
18 shared publications - Johanne Silvain
Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
18 shared publications - Farzin Beygui
CHU Pitié-Salpétrière, Cardiologie, Paris, France
15 shared publications - Guillaume Cayla
CHU Pitié-Salpétrière, Cardiologie, Paris, France
12 shared publications
Latest Publications
- 28 December 2015
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (32) , 2531-2541
Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry
Long distance running races are associated with a low risk of life-threatening events much often attributed to hypertrophic cardiomyopathy. However, retrospective analyses of aetiology lack consistency. Incidence and aetiology of life-threatening/fatal events were assessed in long distance races in the prospective Registre des Accidents Cardiaques lors des courses d'Endurance (RACE Paris Registry) from October 2006 to September 2012. Characteristics of life-threatening/fatal events were analysed by interviewing survivors and reviewing medical records including post-mortem data of each case. Seventeen life-threatening events were identified of 511 880 runners of which two were fatal. The vast majority were cardiovascular events (13/17) occurring in experienced male runners [mean (±SD) age 43 ± 10 years], with infrequent cardiovascular risk factors, atypical warning symptoms prior to the race or negative treadmill test when performed. Acute myocardial ischaemia was the predominant aetiology (8 of 13) and led to immediate myocardial revascularization. All cases with initial shockable rhythm survived. There was no difference in event rate according to marathons vs. half-marathons and events were clustered at the end of the race. A meta-analysis of all available studies including the RACE Paris registry (n = 6) demonstrated a low prevalence of life-threatening events (0.75/100 000) and that presentation with non-shockable rhythm [OR = 29.9; 95% CI (4.0-222.5), P = 0.001] or non-ischaemic aetiology [OR = 6.4; 95% CI (1.4-28.8), P = 0.015] were associated with case-fatality. Life-threatening/fatal events during long distance races are rare, most often unpredictable and mainly due to acute myocardial ischaemia. Presentation with non-shockable rhythm and non-ischaemic aetiology are the major determinant of case fatality.
- 28 December 2015
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (32) , 2531-2541
Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry
Long distance running races are associated with a low risk of life-threatening events much often attributed to hypertrophic cardiomyopathy. However, retrospective analyses of aetiology lack consistency. Incidence and aetiology of life-threatening/fatal events were assessed in long distance races in the prospective Registre des Accidents Cardiaques lors des courses d'Endurance (RACE Paris Registry) from October 2006 to September 2012. Characteristics of life-threatening/fatal events were analysed by interviewing survivors and reviewing medical records including post-mortem data of each case. Seventeen life-threatening events were identified of 511 880 runners of which two were fatal. The vast majority were cardiovascular events (13/17) occurring in experienced male runners [mean (±SD) age 43 ± 10 years], with infrequent cardiovascular risk factors, atypical warning symptoms prior to the race or negative treadmill test when performed. Acute myocardial ischaemia was the predominant aetiology (8 of 13) and led to immediate myocardial revascularization. All cases with initial shockable rhythm survived. There was no difference in event rate according to marathons vs. half-marathons and events were clustered at the end of the race. A meta-analysis of all available studies including the RACE Paris registry (n = 6) demonstrated a low prevalence of life-threatening events (0.75/100 000) and that presentation with non-shockable rhythm [OR = 29.9; 95% CI (4.0-222.5), P = 0.001] or non-ischaemic aetiology [OR = 6.4; 95% CI (1.4-28.8), P = 0.015] were associated with case-fatality. Life-threatening/fatal events during long distance races are rare, most often unpredictable and mainly due to acute myocardial ischaemia. Presentation with non-shockable rhythm and non-ischaemic aetiology are the major determinant of case fatality.
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 5-6
016 High-on thienopyridine platelet reactivity in elderly coronary patients
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 5-6
016 High-on thienopyridine platelet reactivity in elderly coronary patients
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 17
050 Copeptin to improve diagnosis of acute STEMI
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 17
050 Copeptin to improve diagnosis of acute STEMI
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 15
045 New P2Y12 inhibitors versus clopidogrel in primary percutaneous coronary intervention for STEMI: a meta-analysis
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 15
045 New P2Y12 inhibitors versus clopidogrel in primary percutaneous coronary intervention for STEMI: a meta-analysis
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 9
026 Pro-adrenomedullin (MR-proADM) can predict short and long term mortality in STEMI patients
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 9
026 Pro-adrenomedullin (MR-proADM) can predict short and long term mortality in STEMI patients
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 2
004 Contrast induced nephropathy after primary PCI for STEMI: Usefulness of a new definition
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 2
004 Contrast induced nephropathy after primary PCI for STEMI: Usefulness of a new definition
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 44-45
140 Assessment of left main coronary artery lesions by 64 slices coronary tomography: Comparison with IVUS and quantitative coronary angiogram
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 44-45
140 Assessment of left main coronary artery lesions by 64 slices coronary tomography: Comparison with IVUS and quantitative coronary angiogram